Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and in liver transplant recipients
Description
CONCLUSION: After three COVID-19 vaccines, patients with liver disease generally develop robust antibody and T cell responses to vaccination and have mild COVID-19. However, LTR have sustained no/low antibody titres and appear most vulnerable to